Burling Wealth Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Sell
4,840
-406
-8% -$87.4K 0.17% 94
2025
Q4
$1.08M Sell
5,246
-28
-0.5% -$5.27K 0.17% 91
2025
Q3
$828K Sell
5,274
-699
-12% -$108K 0.14% 105
2025
Q2
$1M Sell
5,973
-1,006
-14% -$149K 0.19% 97
2025
Q1
$961K Sell
6,979
-611
-8% -$77.9K 0.2% 94
2024
Q4
$898K Buy
+7,590
New +$886K 0.18% 98

Other funds holding CAH

Burling Wealth Partners's CAH Position: Q1 2026 in Review

Burling Wealth Partners reduced its Cardinal Health (CAH) stake by 7.7% in Q1 2026, selling an estimated $87.4K and leaving 4,840 shares worth $1.02M. The position accounts for 0.17% of the portfolio, ranked #94.

Burling Wealth Partners first reported a position in CAH in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Burling Wealth Partners held 4,840 shares of Cardinal Health worth $1.02M as of Q1 2026.
  • Burling Wealth Partners sold 406 Cardinal Health shares in Q1 2026, an estimated $87.4K.
  • Cardinal Health made up 0.17% of Burling Wealth Partners's portfolio in Q1 2026, its #94 holding.
  • Burling Wealth Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 6 quarters since.
  • Burling Wealth Partners's Cardinal Health position peaked at $1.08M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Burling Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.